Back

Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Subcutaneous ICD Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Markus Linhart

Hospital Clinic of Barcelona, Barcelona (Spain)

9 More presentations in this session

Presentation thumbnail
Eligibility of CRT Patients for Subcutaneous Implantable Cardioverter Defibrillators
Presentation thumbnail
Insight into screening results and post-implantation exercise testing in recipients of a subcutaneous Implantable cardioverter defibrillator
Doctor N. Dayal (Geneva, CH)
Abstract Slides
Presentation thumbnail
Universal S-ICD eligibility: eliminating the need for pre-implant screening using mathematical vector rotation and a gradient filter
Doctor B. Wiles (London, GB)
Abstract Slides
Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: a single center italian experience
Professor F. Migliore (Padova, IT)
Abstract Slides
Presentation thumbnail
Health Care Consumption after ICD/CRT-D replacement: preliminary results from the DECODE registry
Doctor E. Menardi (Vignolo, IT)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Subcutaneous ICD

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources